Ulipristal acetate: understanding its uses for EC and beyond
January 2025. The findings of a proof-of-concept study investigating use of ulipristal acetate (UPA) as part of an abortion regimen, have been published this week. UPA is the active ingredient in the newer generation of emergency contraception (EC) pills. The publication of this research may open a global debate about the development of new indications…